Green growth at Danish biotech firm Novozymes

Denmark's Novozymes saw improvements in the sale of enzymes for production of bioethanol during the first quarter 2017.

Photo: Novozymes

Danish biotech company Novozymes has struggled for years to get its bioenergy business up and running, but the division always lagged behind. However, the company remained optimistic and announced back in January that brighter days were right around the corner.

Where this corner was, and how far Novozymes had to venture to get there, is hard to say. Yet one thing is certain: Novozymes has made significant progress.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from EnergyWatch

Ørsted aims to be number one on carbon capture

The utility hopes to win the Danish carbon capture and storage tender with a plan to capture 400,000 tonnes of CO2 by 2025 from the company’s biomass-fired combined heat and power stations.

Nordex downgrades forecast

The German turbine manufacturer has had a rougher start to 2022 so far than expected, prompting the company to downgrade guidance by EUR 200m at minimum.

Further reading

Related articles

Latest News

See all jobs